Squamous Cell Carcinoma of Head and Neck research hub
3 indexed studies · 3 currently recruiting
- recruitingPHASE2
European Larynx Organ Preservation Study (ELOS) [MK-3475-C44]
This study looks at treating advanced throat cancer (larynx or hypopharynx) with chemotherapy and radiation, adding a new drug, Pembrolizumab (Keytruda®). It aims to see if this new treatment can help patients keep their larynx and live longer, healthier lives.
Germany - recruiting
Workshops and Exchange Groups for Laryngectomized Patients
This study looks at how workshops and support groups can help people who have had their voice box (larynx) removed due to cancer. It aims to improve their quality of life by helping them adjust to changes in speaking, breathing, and daily life.
France - recruiting
Immune Biomarker Study for Head and Neck Cancer
This study looks at how your body's defence system (immune system) reacts to head and neck cancer. Researchers want to find early warning signs in your blood and tumour to help predict how the cancer might behave and improve future treatments.
Germany